Literature DB >> 32269733

Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Feifei Bi1, Qiwei Wang1, Qian Dong1, Yuanhe Wang1, Liqun Zhang1, Jingdong Zhang1.   

Abstract

Tumor biopsy is the standard method for cancer diagnosis and provides an important sample for pathological assessment. With the development of precision medicine, liquid biopsies are now an important tool to detect molecular changes and tumor heterogeneity. In recent years, research related to circulating tumor DNA (ctDNA) has intensified due to its non-invasive, convenient, comprehensive, and safety characteristics. Herein, we provide a review describing the clinical applications and prospects of ctDNA in colorectal cancer (CRC) diagnosis, monitoring and prognosis. AJTR
Copyright © 2020.

Entities:  

Keywords:  Liquid biopsy; circulating tumor DNA; colorectal cancer

Year:  2020        PMID： 32269733      PMCID： PMC7137038     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN： 1943-8141            Impact factor:   4.060


  69 in total

1.  About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.

Authors:  M Stroun; J Lyautey; C Lederrey; A Olson-Sand; P Anker
Journal:  Clin Chim Acta       Date:  2001-11       Impact factor: 3.786

2.  Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.

Authors:  Milo Frattini; Debora Balestra; Paolo Verderio; Gianfrancesco Gallino; Ermanno Leo; Gabriella Sozzi; Marco A Pierotti; Maria Grazia Daidone
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

3.  Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma.

Authors:  T H Lee; L Montalvo; V Chrebtow; M P Busch
Journal:  Transfusion       Date:  2001-02       Impact factor: 3.157

4.  Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.

Authors:  Emanuela Flamini; Laura Mercatali; Oriana Nanni; Daniele Calistri; Roberta Nunziatini; Wainer Zoli; Paola Rosetti; Nice Gardini; Arturo Lattuneddu; Giorgio Maria Verdecchia; Dino Amadori
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

5.  Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Authors:  Wendy De Roock; Bart Claes; David Bernasconi; Jef De Schutter; Bart Biesmans; George Fountzilas; Konstantine T Kalogeras; Vassiliki Kotoula; Demetris Papamichael; Pierre Laurent-Puig; Frédérique Penault-Llorca; Philippe Rougier; Bruno Vincenzi; Daniele Santini; Giuseppe Tonini; Federico Cappuzzo; Milo Frattini; Francesca Molinari; Piercarlo Saletti; Sara De Dosso; Miriam Martini; Alberto Bardelli; Salvatore Siena; Andrea Sartore-Bianchi; Josep Tabernero; Teresa Macarulla; Frédéric Di Fiore; Alice Oden Gangloff; Fortunato Ciardiello; Per Pfeiffer; Camilla Qvortrup; Tine Plato Hansen; Eric Van Cutsem; Hubert Piessevaux; Diether Lambrechts; Mauro Delorenzi; Sabine Tejpar
Journal:  Lancet Oncol       Date:  2010-07-08       Impact factor: 41.316

6.  Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.

Authors:  Joel Petit; Georgia Carroll; Tiffany Gould; Peter Pockney; Matthew Dun; Rodney J Scott
Journal:  J Surg Res       Date:  2018-12-21       Impact factor: 2.192

Review 7.  Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges.

Authors:  Patrick E Young; Craig M Womeldorph; Eric K Johnson; Justin A Maykel; Bjorn Brucher; Alex Stojadinovic; Itzhak Avital; Aviram Nissan; Scott R Steele
Journal:  J Cancer       Date:  2014-03-15       Impact factor: 4.207

Review 8.  The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.

Authors:  Ian A Cree; Lesley Uttley; Helen Buckley Woods; Hugh Kikuchi; Anne Reiman; Susan Harnan; Becky L Whiteman; Sian Taylor Philips; Michael Messenger; Angela Cox; Dawn Teare; Orla Sheils; Jacqui Shaw
Journal:  BMC Cancer       Date:  2017-10-23       Impact factor: 4.430

9.  Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.

Authors:  Thomas Reinert; Tenna Vesterman Henriksen; Emil Christensen; Shruti Sharma; Raheleh Salari; Himanshu Sethi; Michael Knudsen; Iver Nordentoft; Hsin-Ta Wu; Antony S Tin; Mads Heilskov Rasmussen; Søren Vang; Svetlana Shchegrova; Amanda Frydendahl Boll Johansen; Ramya Srinivasan; Zoe Assaf; Mustafa Balcioglu; Alexander Olson; Scott Dashner; Dina Hafez; Samantha Navarro; Shruti Goel; Matthew Rabinowitz; Paul Billings; Styrmir Sigurjonsson; Lars Dyrskjøt; Ryan Swenerton; Alexey Aleshin; Søren Laurberg; Anders Husted Madsen; Anne-Sofie Kannerup; Katrine Stribolt; Søren Palmelund Krag; Lene H Iversen; Kåre Gotschalck Sunesen; Cheng-Ho Jimmy Lin; Bernhard G Zimmermann; Claus Lindbjerg Andersen
Journal:  JAMA Oncol       Date:  2019-08-01       Impact factor: 31.777

10.  A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer.

Authors:  Xiaofeng Chen; Tianzhu Qiu; Yingwei Zhu; Jing Sun; Ping Li; Biao Wang; Peinan Lin; Xiaomin Cai; Xiao Han; Fengjiao Zhao; Yongqian Shu; Lianpeng Chang; Hua Jiang; Yanhong Gu
Journal:  Oncologist       Date:  2019-03-15
View more
  8 in total

Review 1.  Overview of serum and tissue markers in colorectal cancer: a primer for radiologists.

Authors:  Apurva Bonde; Daniel A Smith; Elias Kikano; Jennifer M Yoest; Sree H Tirumani; Nikhil H Ramaiya
Journal:  Abdom Radiol (NY)       Date:  2021-08-20

Review 2.  The current state of molecular profiling in gastrointestinal malignancies.

Authors:  Reetu Mukherji; Chao Yin; Rumaisa Hameed; Ali Z Alqahtani; Monika Kulasekaran; Aiwu R He; Benjamin A Weinberg; John L Marshall; Marion L Hartley; Marcus S Noel
Journal:  Biol Direct       Date:  2022-06-06       Impact factor: 7.173

Review 3.  Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.

Authors:  William M Grady; Ming Yu; Sanford D Markowitz
Journal:  Gastroenterology       Date:  2020-12-03       Impact factor: 22.682

4.  The Diagnostic and Prognostic Value of Serum lncRNA NEAT1 in Colorectal Cancer.

Authors:  Yong Wang; Dongsheng Zhang; Chuan Zhang; Yueming Sun
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

5.  Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion.

Authors:  Zhihua Miao; Tianhao Mu; Longying Liu; Jingjie Rao; Min Jin; Zhizheng Wang; Hui Wang; Chao Lu; Xiaolin Gong; Dongcai Zheng; Daoming Zheng; Xin Li; Yingmei Li; Shifu Chen; Xinhua Shu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

Review 6.  Microsatellite Instability in Colorectal Cancer Liquid Biopsy-Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker.

Authors:  Francis Yew Fu Tieng; Nadiah Abu; Learn-Han Lee; Nurul-Syakima Ab Mutalib
Journal:  Diagnostics (Basel)       Date:  2021-03-18

Review 7.  Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer.

Authors:  Jun Gong; Andrew Hendifar; Alexandra Gangi; Karen Zaghiyan; Katelyn Atkins; Yosef Nasseri; Zuri Murrell; Jane C Figueiredo; Sarah Salvy; Robert Haile; Megan Hitchins
Journal:  Cancers (Basel)       Date:  2021-09-10       Impact factor: 6.639

8.  The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.

Authors:  Harper L Wilson; Ralph B D'Agostino; Nuwan Meegalla; Robin Petro; Sara Commander; Umit Topaloglu; Wei Zhang; Mercedes Porosnicu
Journal:  Oncologist       Date:  2020-11-20       Impact factor: 5.837
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.